Healthcare & Life Sciences
Lyell Immunopharma
United Stateswww.lyell.com
Lyell Immunopharma is a series c plus startup based in United States. 1 investor tracked. Status: ipo.
iposeries-c-plus
series-c-plus
Stage
2017
Founded
3
Investors
About
Lyell Immunopharma is a series c plus startup based in United States. 1 investor tracked. Status: ipo.
Explore Lyell Immunopharma's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.